1998
DOI: 10.1006/geno.1998.5095
|View full text |Cite
|
Sign up to set email alerts
|

Discovery of Three Novel G-Protein-Coupled Receptor Genes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
199
0
3

Year Published

1999
1999
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 270 publications
(206 citation statements)
references
References 18 publications
4
199
0
3
Order By: Relevance
“…Importantly, GPR30 is abundantly expressed in ERα-positive breast cancer cells, with little or no expression detected in ERα-negative cells (Carmeci et al, 1997). Northern blot and in situ hybridization analysis has revealed that GPR30 is expressed in most tissues and distributed throughout many different brain regions (O'Dowd et al, 1998). In the rat, we have also independently confirmed at GPR30 mRNA and protein is widely distributed and is detected in most tissues.…”
Section: Gpr30 As a Rapidly Acting Mersupporting
confidence: 57%
“…Importantly, GPR30 is abundantly expressed in ERα-positive breast cancer cells, with little or no expression detected in ERα-negative cells (Carmeci et al, 1997). Northern blot and in situ hybridization analysis has revealed that GPR30 is expressed in most tissues and distributed throughout many different brain regions (O'Dowd et al, 1998). In the rat, we have also independently confirmed at GPR30 mRNA and protein is widely distributed and is detected in most tissues.…”
Section: Gpr30 As a Rapidly Acting Mersupporting
confidence: 57%
“…In the late 1990's, a putative GPCR was cloned by 4 different groups using highly disparate approaches (Carmeci et al, 1997;O'Dowd et al, 1998;Owman et al, 1996;Takada et al, 1997). The GPCR identified in these studies displayed little homology to other GPCRs.…”
Section: G Protein-coupled Seven Transmembrane Estrogen Receptorsmentioning
confidence: 99%
“…NM_001505) which was mapped on 7p22.3. (23) When the mutation search was carried out to check if the subtracted clone, the GPR30 3′UTR fragment (approximately 300 bp) would contain genomic aberration, we identified a 2 bpdeletion (Cytosine and Thymine; CT) in the genomic DNA pair of gastric cancer. The database search showed that the 2 bpdeleted GPR30 had been reported as 'FEG-1' (Accession No.…”
Section: Resultsmentioning
confidence: 99%